Pandemics : Insurance and Social Protection.

Bibliographic Details
Main Author: Boado-Penas, María del Carmen.
Other Authors: Eisenberg, Julia., Şahin‬‬‬, Şule.
Format: eBook
Language:English
Published: Cham : Springer International Publishing AG, 2021.
Edition:1st ed.
Series:Springer Actuarial Series
Subjects:
Online Access:Click to View
Table of Contents:
  • Intro
  • Preface
  • Acknowledgements
  • Contents
  • Contributors
  • 1 COVID-19: A Trigger for Innovations in Insurance?
  • 1.1 Introduction
  • 1.2 Discussions from the Perspective of Insurance and Social Protection
  • 1.2.1 Commercial Insurance
  • 1.2.2 The Role of the Governments and Social Protection
  • 1.3 Listening to the Wind of Change
  • References
  • 2 Epidemic Compartmental Models and Their Insurance Applications
  • 2.1 Introduction
  • 2.2 Compartmental Models in Epidemiology
  • 2.2.1 SIR Model
  • 2.2.2 Other Compartmental Models
  • 2.3 Epidemic Insurance
  • 2.3.1 Annuities and Insurance Benefits
  • 2.3.2 Reserves
  • 2.3.3 Further Extensions
  • 2.3.4 Case Studies: COVID-19
  • 2.4 Resource Management
  • 2.4.1 Pillar I: Regional and Aggregate Resources Demand Forecast
  • 2.4.2 Pillar II: Centralised Stockpiling and Distribution
  • 2.4.3 Pillar III: Centralised Resources Allocation
  • 2.5 Conclusion
  • References
  • 3 Some Investigations with a Simple Actuarial Model for Infections Such as COVID-19
  • 3.1 Introduction
  • 3.2 Multiple State Actuarial Models
  • 3.3 A Simple Daily Model for Infection
  • 3.4 Comparisons with the SIR Model
  • 3.5 Enhancements for COVID-19 and Initial Assumptions
  • 3.6 Estimating Parameters Model 1
  • 3.7 Estimating Parameters Model 2
  • 3.8 Comments on Results of Models 1 and 2
  • 3.9 Further Extensions: Models 3 and 4
  • 3.10 Comments on Results of Models 3 and 4
  • 3.11 Projection Models
  • 3.12 Problems and Unknowns
  • 3.13 Other Countries
  • 3.14 Conclusions
  • References
  • 4 Stochastic Mortality Models and Pandemic Shocks
  • 4.1 Stochastic Mortality Models and the COVID-19 Shock
  • 4.2 The Impact of COVID-19 on Mortality Rates
  • 4.3 Stochastic Mortality Models and Pandemics: Single-Population Models
  • 4.3.1 Discrete-Time Single Population Models
  • 4.3.2 Continuous-Time Single-Population Models.
  • 4.4 Stochastic Mortality Models and Pandemics: Multi-population
  • 4.4.1 Discrete-Time Models
  • 4.4.2 Continuous-Time Models
  • 4.5 A Continuous-Time Multi-population Model with Jumps
  • 4.6 Conclusions
  • References
  • 5 A Mortality Model for Pandemics and Other Contagion Events
  • 5.1 Introduction
  • 5.2 Highlights of Methodology and Findings
  • 5.2.1 Summary of Methodology
  • 5.2.2 Summary of Findings
  • 5.3 Semiparametric Regression in MCMC
  • 5.3.1 MCMC Parameter Shrinkage
  • 5.3.2 Spline Regressions
  • 5.3.3 Why Shrinkage?
  • 5.3.4 Cross Validation in MCMC
  • 5.4 Model Details
  • 5.4.1 Formulas
  • 5.4.2 Fitting Process
  • 5.5 Results
  • 5.5.1 Extensions: Generalisation, Projections and R Coding
  • 5.6 Conclusions
  • References
  • 6 Risk-Sharing and Contingent Premia in the Presence of Systematic Risk: The Case Study of the UK COVID-19 Economic Losses
  • 6.1 Introduction
  • 6.2 Risk Levels and Systematic Risk in Insurance
  • 6.3 Mathematical Setup
  • 6.3.1 Probability Space
  • 6.3.2 Insurance Preliminaries
  • 6.4 Risk Management Platforms
  • 6.4.1 Risk-Sharing Platform
  • 6.4.2 Insurance Platform
  • 6.4.3 Market Platform
  • 6.5 Systematic Risk Model and Common Shocks
  • 6.5.1 Additive Common Shock Model
  • 6.5.2 Multiplicative Common Shock Model
  • 6.5.3 Risk Rate Common Shock Model
  • 6.6 Conclusion
  • References
  • 7 All-Hands-On-Deck!-How International Organisations Respond to the COVID-19 Pandemic
  • 7.1 Introduction
  • 7.2 The EU Response to COVID-19
  • 7.2.1 EU Commission Response
  • 7.2.2 The ECDC Response
  • 7.3 The World Bank Response to COVID-19
  • 7.3.1 Pandemic Emergency Financial Facility (PEF)
  • 7.4 Other International Responses to COVID-19
  • 7.4.1 The UN Response
  • 7.4.2 The WHO Response
  • 7.4.3 The OECD Response
  • 7.4.4 The ILO Response
  • 7.5 Consequences of COVID-19 Responses on Social Security and Pensions.
  • 7.6 The Need of a United Action Tactic
  • References
  • 8 Changes in Behaviour Induced by COVID-19: Obedience to the Introduced Measures
  • 8.1 Introduction: Pandemics and Isolation
  • 8.2 Obedience to the Introduced Rules After COVID-19 Across Countries
  • 8.2.1 Citizens' Demographic Characteristics
  • 8.2.2 Cultural Tradition
  • 8.3 Behavioural Changes Due to COVID-19
  • 8.3.1 Consumption Patterns
  • 8.3.2 Unhealthy Consumption Habits
  • 8.3.3 Teleworking
  • 8.3.4 Gender and Family Violence
  • 8.4 Discussion and Conclusions
  • References
  • 9 COVID-19 and Optimal Lockdown Strategies: The Effect of New and More Virulent Strains
  • 9.1 Introduction
  • 9.1.1 The Challenge of New Virus Variants
  • 9.1.2 Review of Past Findings
  • 9.1.3 Review of Other Related Literature
  • 9.2 The Optimal Start and Length of a Lockdown
  • 9.2.1 The Model
  • 9.2.2 Results
  • 9.3 The Optimal Lockdown Intensity
  • 9.3.1 Results
  • 9.4 Discussion
  • References
  • 10 Diagnostic Tests and Procedures During the COVID-19 Pandemic
  • 10.1 Introduction
  • 10.2 Laboratory Diagnosis: Pre-analytical Issues
  • 10.2.1 Specimen Types and Specimen Collection
  • 10.2.2 Biosafety Considerations
  • 10.3 Laboratory Diagnosis: Analytical Issues
  • 10.3.1 Non-molecular Methods
  • 10.3.2 Molecular Methods
  • 10.3.3 Point-of-Care and Home Sample Collection and Testing
  • 10.3.4 Assay Selection
  • 10.3.5 Pooled Screen Testing
  • 10.3.6 Viral Load Testing
  • 10.4 Laboratory Diagnosis: Post-analytical Issues
  • 10.5 Interpretation of Serology Results
  • 10.5.1 Interpretation of Molecular Results
  • 10.5.2 Tests Beyond Detection and Diagnosis
  • 10.6 Concluding Remarks
  • References
  • 11 Pooled Testing and Its Applications in the COVID-19 Pandemic
  • 11.1 Introduction
  • 11.1.1 Testing for COVID-19
  • 11.1.2 Stages of a Pooled Testing Algorithm
  • 11.1.3 Who and Why to Test.
  • 11.2 Pooled Testing Algorithms for Perfect Tests
  • 11.2.1 Outline and Model
  • 11.2.2 Individual Testing
  • 11.2.3 Dorfman's Algorithm
  • 11.2.4 Grid Algorithms
  • 11.2.5 Pooling Algorithms Based on (r,s)-Regular Designs
  • 11.3 Pooled Testing Algorithms for Imperfect Tests
  • 11.3.1 The Model
  • 11.3.2 Analysis of Individual Testing and Dorfman's Algorithm
  • 11.3.3 One-Stage Testing
  • 11.4 Practical Challenges for Pooled Testing
  • 11.5 Uses of Pooled Testing in the COVID-19 Pandemic
  • 11.5.1 Dorfman's Algorithm at the University of Cambridge
  • 11.5.2 The Grid and P-BEST Algorithms in Israel
  • 11.5.3 A Multi-stage (r,s)-Regular Algorithm in Rwanda
  • 11.5.4 Other Uses of Pooled Testing
  • 11.6 Applications of Pooled Testing for COVID-19: Some Conclusions
  • 11.6.1 Pooled Testing for Asymptomatic Subpopulations
  • 11.6.2 Pooled Testing and Vaccination Programmes
  • 11.6.3 Pooled Testing for Surveillance
  • References
  • 12 Outlier Detection for Pandemic-Related Data Using Compositional Functional Data Analysis
  • 12.1 Introduction
  • 12.1.1 Compositional Data Analysis Concepts
  • 12.1.2 Functional Data
  • 12.2 Smoothing for CODA Time Series
  • 12.3 Outlier Detection in Compositional FDA
  • 12.4 Application to COVID-19 Data
  • 12.5 Summary and Conclusions
  • References
  • 13 The Legal Challenges of Insuring Against a Pandemic
  • 13.1 Introduction
  • 13.2 Summary of the Traditional Approach to Insurance
  • 13.2.1 The Origins of Insurance
  • 13.2.2 The Insurance Indemnity Principle
  • 13.3 The Effect of COVID-19 on the Insurance Industry
  • 13.3.1 The Effect of COVID-19 on Business Interruption Insurance Policyholders
  • 13.3.2 The Effect of COVID-19 on Insurers
  • 13.4 Life Insurance Versus Business Interruption Insurance
  • 13.5 Why Existing Indemnity Based Pandemic Insurance Products Are Not Working.
  • 13.6 Proposals Across the World for Resolving the Business Interruption Insurance Deficit
  • 13.7 What Is Parametric Insurance?
  • 13.7.1 Working Examples of Parametric Insurance
  • 13.7.2 Challenges
  • 13.7.3 Opportunities
  • 13.7.4 Could Parametric Insurance Be the Answer for SMEs During a Pandemic?
  • References
  • 14 An Actuary's Opinion: How to Get Through a Pandemic
  • 14.1 Questions to Be Tackled from an Actuary's Perspective
  • 14.2 Managing a Pandemic as a (Re)insurer
  • 14.2.1 Insurability of a Pandemic
  • 14.2.2 Risk Management During a Pandemic
  • 14.2.3 Reflecting Potential Future Consequences of COVID-19
  • 14.3 Managing Pandemics from a Governmental Perspective
  • 14.3.1 Deciding on the Right Measures During a Pandemic
  • 14.3.2 Mitigating Economic Risks for Future Pandemics
  • 14.4 Conclusion: Our Learnings
  • References.